Stocklytics Platform
Asset logo for symbol RPRX
Royalty Pharma PLC
RPRX58
$24.92arrow_drop_up2.71%$0.66
Asset logo for symbol RPRX
RPRX58

$24.92

arrow_drop_up2.71%

Income Statement (RPRX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT$735.07M$0.00-$689.81M$672.44M$166.53M
EBITDA$872.86M$560.00M$39.95M$673.86M$167.94M
gross Profit$563.03M$531.26M-$15.62M$519.48M$259.17M
NET Income$543.98M$102.00M$4.77M$494.34M$72.11M
total Revenue$564.69M$537.26M$567.97M$596.00M$536.31M

Balance Sheet (RPRX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt$6.65B$5.83B$5.29B$5.65B$5.19B
stockholders Equity$6.86B$6.47B$6.49B$6.52B$6.13B
total Assets$18.04B$17.65B$16.13B$16.38B$15.85B
total Debt$7.60B$7.60B$6.13B$6.13B$6.13B
total Liabilities$7.78B$7.90B$6.26B$6.29B$6.27B

Cash Flow (RPRX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow-$325.50M$1.15B-$213.42M-$237.97M-$1.35B
free Cash Flow$1.52B-$84.47M$583.51M-$224.95M$573.52M
investing Cash Flow-----
operating Cash Flow$703.61M$662.15M$669.60M$777.28M$573.52M

Royalty Pharma PLC (RPRX) Financials

The income statement for Royalty Pharma PLC (RPRX) provides a snapshot of the company's financial performance. It shows the revenue generated from its operations and the expenses incurred to generate that revenue. The income statement also includes key measures such as EBIT (Earnings Before Interest and Taxes) and EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization). EBIT represents the company's operating income before deducting interest and taxes, while EBITDA adds back non-cash expenses like depreciation and amortization. These measures help assess the company's profitability and operating efficiency.
Another important figure on the income statement is the gross profit, which is the revenue minus the cost of goods sold. It indicates how much profit the company makes from its core operations. The net income from stockholders represents the profit that is attributable to the company's shareholders after deducting taxes and other expenses. Overall, the income statement provides a comprehensive view of the company's earnings, expenses, and profitability.
add Royalty Pharma PLC to watchlist

Keep an eye on Royalty Pharma PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level